Found 81 matching trials
Personalized Neoantigen Peptide Vaccines for Solid Tumors
PHASE1This clinical trial is studying the safety and efficacy of a personalized c...
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)
PHASE2In this study, the investigators provide an individualized tumor neoantigen...
Location
University of Hong Kong-Shenzhen Hospital
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
PHASE1This research study is studying the drugs called NeoVax (a new type of pers...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
PHASE2The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Location
Second Affiliated Hospital of Wenzhou Medical University
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
PHASE1This is a phase I, open label, plus expansion clinical trial evaluating the...
Location
Children's Health Orange County (CHOC)
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
PHASE1The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NAIn this study, the investigators provide a combined treatment of personaliz...
Location
First Affiliated Hospital of Nanchang University
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
PHASE1This study study aims to elucidate the immune responses to a shared antigen...
Location
Washington University School of Medicine
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
EARLY_PHASE1This is an early phase I, single-arm, open-label clinical study designed to...
Location
Biogenea Pharmaeuticals Ltd
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
PHASE1This phase I/II trial tests the safety and tolerability of an experimental ...
Location
Mayo Clinic in Florida